Sponsors: []Modifications: (2)  AB-PINACA;N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;(3)  AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide;(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)  MAM-2201;(1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;(36)(37)(38)  PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57)(58)(59)(60)(61)(62)(63)(64)(65)(66)  5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinylester;(67)(68)(69)(70); and(71)  25H-NBOMe;2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.If approved by two-thirds of all the members elected to each house, this bill takes effectupon approval by the governor, or the day following the constitutional time limit of UtahConstitution Article VII, Section 8, without the governor's signature, or in the case of a veto,the date of veto override.Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

H.B. 30





            
1

    
 CONTROLLED SUBSTANCES AMENDMENTS



            
2

    
2014 GENERAL SESSION

            
3

    
STATE OF UTAH

            
4

    


 Chief Sponsor:  Paul Ray



            
5

    



Senate Sponsor: 






  Allen M. Christensen





            
6

    

            
7

    
 LONG TITLE
            
8

    
 Committee Note:
            
9

    
    The Law Enforcement and Criminal Justice Interim Committee recommended this bill.
            
10

    
 General Description:
            
11

    
    This bill modifies Title 58, Chapter 37, Utah Controlled Substances Act, by adding
            
12

    
controlled substances.
            
13

    
 Highlighted Provisions:
            
14

    
    This bill:
            
15

    
    .    adds new "spice" and emerging drug analogs to the listed controlled substances.
            
16

    
 Money Appropriated in this Bill:
            
17

    
    None
            
18

    
 Other Special Clauses:
            
19

    
    This bill provides an immediate effective date.
            
20

    
 Utah Code Sections Affected:
            
21

    
AMENDS:
            
22

    
     
58-37-4.2
, as last amended by Laws of Utah 2013, Chapters 83 and 88
            
23

    

            
24

    
Be it enacted by the Legislature of the state of Utah:
            
25

    
    Section 1.  
Section  
58-37-4.2

 is amended to read:
            
26

    
     58-37-4.2.  Listed controlled substances.
            
27

    
    The following substances, their analogs, homologs, and synthetic equivalents are listed

            
28


    
controlled substances:
            
29

    
    (1)  AB-001;
            
30

    
    (2)  AB-PINACA;
            
31

    
N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;
            
32

    
    (3)  AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)
            
33

    
methyl]-1H-indazole-3-carboxamide;
            
34

    
    [(2)] (4)  AKB48;
            
35

    
    [(3)] (5)  alpha-Pyrrolidinovalerophenone (alpha-PVP);
            
36

    
    [(4)] (6)  AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
            
37

    
    [(5)] (7)  AM-1248;
            
38

    
    [(6)] (8)  AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
            
39

    
    [(7)] (9)  AM-2233;
            
40

    
    [(8)] (10)  AM-679;
            
41

    
    [(9)] (11)  A796,260;
            
42

    
    [(10)] (12)  Butylone;
            
43

    
    [(11)] (13)  CP 47,497 and its C6, C8, and C9 homologs;
            
44

    
2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;
            
45

    
    [(12)] (14)  Diisopropyltryptamine (DiPT);
            
46

    
    [(13)] (15)  Ethylone;
            
47

    
    [(14)] (16)  Ethylphenidate;
            
48

    
    [(15)] (17)  Fluoroisocathinone;
            
49

    
    [(16)] (18)  Fluoromethamphetamine;
            
50

    
    [(17)] (19)  Fluoromethcathinone;
            
51

    
    [(18)] (20)  HU-210;
            
52

    
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
            
53

    
-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
            
54

    
    [(19)] (21)  HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
            
55

    
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
            
56

    
    [(20)] (22)  JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
            
57

    
    [(21)] (23)  JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
            
58

    
1-Pentyl-3-(1-naphthoyl)indole};

            
59


    
    [(22)] (24)  JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
            
60

    
    [(23)] (25)  JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
            
61

    
1-Butyl-3-(1-naphthoyl)indole};
            
62

    
    [(24)] (26)  JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
            
63

    
    [(25)] (27)  JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
            
64

    
    [(26)] (28)  JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
            
65

    
    [(27)] (29)  JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
            
66

    
    [(28)] (30)  JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
            
67

    
    [(29)] (31)  JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
            
68

    
    [(30)] (32)  JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
            
69

    
    [(31)] (33)  JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
            
70

    
    [(32)] (34)  MAM-2201;
            
71

    
    (35)  MAM-2201;
            
72

    
(1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;
            
73

    
    [(33)] (36)  Methoxetamine;
            
74

    
    [(34)] (37)  Naphyrone;
            
75

    
    (38)  PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;
            
76

    
    [(35)] (39)  Pentedrone;
            
77

    
    [(36)] (40)  Pentylone;
            
78

    
    [(37)] (41)  RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
            
79

    
    [(38)] (42)  RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
            
80

    
known as BTW-8 and SR-18};
            
81

    
    [(39)] (43)  STS-135;
            
82

    
    [(40)] (44)  UR-144;
            
83

    
    [(41)] (45)  UR-144 N-(5-chloropentyl) analog;
            
84

    
    [(42)] (46)  XLR11;
            
85

    
    [(43)] (47)  2C-C;
            
86

    
    [(44)] (48)  2C-D;
            
87

    
    [(45)] (49)  2C-E;
            
88

    
    [(46)] (50)  2C-H;
            
89

    
    [(47)] (51)  2C-I;

            
90


    
    [(48)] (52)  2C-N;
            
91

    
    [(49)] (53)  2C-P;
            
92

    
    [(50)] (54)  2C-T-2;
            
93

    
    [(51)] (55)  2C-T-4;
            
94

    
    [(52)] (56)  2NE1;
            
95

    
    [(53)] (57)  25I-NBOMe;
            
96

    
    [(54)] (58)  2,5-Dimethoxy-4-chloroamphetamine (DOC);
            
97

    
    [(55)] (59)  4-methylmethcathinone {also known as mephedrone};
            
98

    
    [(56)] (60)  3,4-methylenedioxypyrovalerone {also known as MDPV};
            
99

    
    [(57)] (61)  3,4-Methylenedioxymethcathinone {also known as methylone};
            
100

    
    [(58)] (62)  4-methoxymethcathinone;
            
101

    
    [(59)] (63)  4-Methyl-alpha-pyrrolidinopropiophenone;
            
102

    
    [(60)] (64)  4-Methylethcathinone;
            
103

    
    [(61)] (65)  5F-AKB48;
            
104

    
1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;
            
105

    
    (66)  5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl
            
106

    
ester;
            
107

    
    [(62)] (67)  5-Iodo-2-aminoindane (5-IAI);
            
108

    
    [(63)] (68)  5-MeO-DALT;
            
109

    
    [(64)] (69)  25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
            
110

    
methyl]ethanamine; [and]
            
111

    
    [(65)] (70)  25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
            
112

    
methyl]ethanamine[.]; and
            
113

    
    (71)  25H-NBOMe;
            
114

    
2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
            
115

    
    Section 2.   Effective date.
            
116

    
    If approved by two-thirds of all the members elected to each house, this bill takes effect
            
117

    
upon approval by the governor, or the day following the constitutional time limit of Utah
            
118

    
Constitution Article VII, Section 8, without the governor's signature, or in the case of a veto,
            
119

    
the date of veto override.





 Legislative Review Note
    as of  11-5-13  3:52 PM

 Office of Legislative Research and General Counsel
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







